PlainRecalls
FDA Drug Critical Class I Terminated

Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01); For IM or IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Reported: February 3, 2021 Initiated: December 23, 2020 #D-0245-2021

Product Description

Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01); For IM or IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Reason for Recall

Presence of Particulate Matter - found in reserve sample vials at the firm.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
945,425 vials
Distribution
Nationwide USA and Puerto Rico
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01); For IM or IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.. Recalled by Fresenius Kabi USA, LLC. Units affected: 945,425 vials.
Why was this product recalled?
Presence of Particulate Matter - found in reserve sample vials at the firm.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 3, 2021. Severity: Critical. Recall number: D-0245-2021.